Michael Egholm - 07 Oct 2021 Form 3 Insider Report for IsoPlexis Corp

Reporting relationship: Director
Issuer ticker: N/A
Reported as of: 07 Oct 2021
Net transaction value: $0
SEC form: 3
Accepted by SEC: 07 Oct 2021, 16:57:48 UTC
Next SEC filing: 06 Apr 2022
Source filing: View source filing
Reporting owner signature: /s/ Shane Sevier, attorney-in-fact for Michael Egholm

Key filing fact

Michael Egholm filed Form 3 for IsoPlexis Corp on 07 Oct 2021.

Key facts

This page summarizes Michael Egholm's Form 3 filing for IsoPlexis Corp.
0 reported transactions and 1 derivative row are listed below.
Accepted by SEC: 07 Oct 2021, 16:57.

Change

No earlier filing in this sequence is available for direct comparison.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Official SEC source

Ownership activity is grounded in SEC Form 3 disclosures.

View source filing

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

ISO holding Derivative

Stock Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
Date: 07 Oct 2021
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 40,000
Exercise price: $10.72
Footnotes: F1

^* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 1 footnote

Footnote F1

Represents 40,000 time-vesting options. Time-vesting options are subject to a four-year time-based vesting schedule, with 25% vesting on July 19, 2022 and the remainder vesting in 36 equal installments every month thereafter.

SEC remarks

Exhibit 24 - Power of Attorney